Showing results (51-60 of 419) with videos related to

Sort By:
Pageof 42
Transplant International : Official Journal of the European Society for Organ Transplantation|May 21, 2009
Treatment of symptomatic transplant glomerulopathy with rituximabLionel Rostaing, Céline Guilbeau-Frugier, Marylise Fort, et al.
Transplantation|March 11, 2011
CYP3A5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipientsNicolas Picard, Koukeb Rouguieg-Malki, Nassim Kamar, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 26, 2013
Long-term outcome of reusing a kidney allograft retrieved from a living recipient and retransplanted into a second recipientJulie Bellière, Federico Sallusto, Céline Guilbeau-Frugier, et al.
Expert Review of Clinical Pharmacology|December 23, 2015
Belatacept prophylaxis against organ rejection in adult kidney-transplant recipientsArnaud Del Bello, Olivier Marion, David Milongo, et al.
Presse Medicale (Paris, France : 1983)|February 3, 2015
[Treatment of hepatitis E virus infection]Nassim Kamar, Lionel Rostaing, Laurent Alric, et al.
Transplantation Proceedings|April 21, 2026
Unmasking a Silent Risk: Impact of Baseline Hypotension on Kidney Allograft Outcomes in Comparison With Normotensive RecipientsMoatasem Ghoneim, Ahmed Mohamed Naguib Attiya, Lionel Rostaing, et al.
Annals of Transplantation|July 15, 2014
The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET studyLionel Rostaing, Maarten H L Christiaans, John M Kovarik, et al.
Basic and Clinical Andrology|March 18, 2015
A prospective study in male recipients of kidney transplantation reveals divergent patterns for inhibin B and testosterone secretionsSafouane M Hamdi, Marie Walschaerts, Louis Bujan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 1, 2007
Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overviewEric Huyghe, Anas Zairi, Joe Nohra, et al.
Pageof 42